Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China
- DOI
- 10.1080/14796694.2026.2677771
- Published
- 2026-05-27
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2677771,
title = {Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China},
author = {Zhiqiang Wang and Haijun Zhong and Yifu He and Chen Zhang and Zuoxing Niu and Shujun Yang and Tao Zhang and Liangjun Zhu and Yongqian Shu and Jianjun Peng and Yan Song and Jian Li and Ying Yuan and Haibo Zhang and Gengsheng Yu and Yunqi Hua and Jianjun Xiao and Jianfei Fu and Yulong Zheng and Jingyu Zhu and Hua Xue and Xian Luo and Weiguo Su and Shukui Qin and Jin Li},
year = {2026},
journal = {Future Oncology},
doi = {10.1080/14796694.2026.2677771},
url = {https://doi.org/10.1080/14796694.2026.2677771}
}RIS
TY - JOUR TI - Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China AU - Zhiqiang Wang AU - Haijun Zhong AU - Yifu He AU - Chen Zhang AU - Zuoxing Niu AU - Shujun Yang AU - Tao Zhang AU - Liangjun Zhu AU - Yongqian Shu AU - Jianjun Peng AU - Yan Song AU - Jian Li AU - Ying Yuan AU - Haibo Zhang AU - Gengsheng Yu AU - Yunqi Hua AU - Jianjun Xiao AU - Jianfei Fu AU - Yulong Zheng AU - Jingyu Zhu AU - Hua Xue AU - Xian Luo AU - Weiguo Su AU - Shukui Qin AU - Jin Li PY - 2026 JO - Future Oncology DO - 10.1080/14796694.2026.2677771 UR - https://doi.org/10.1080/14796694.2026.2677771 ER -
APA
Wang, Z., Zhong, H., He, Y., Zhang, C., Niu, Z., Yang, S., Zhang, T., Zhu, L., Shu, Y., Peng, J., Song, Y., Li, J., Yuan, Y., Zhang, H., Yu, G., Hua, Y., Xiao, J., Fu, J., Zheng, Y., Zhu, J., Xue, H., Luo, X., Su, W., Qin, S., & Li, J. (2026). Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China. Future Oncology. https://doi.org/10.1080/14796694.2026.2677771
Source records
- crossref · retrieved 2026-09-27T10:31:09.216Z